LifeMD, Inc. (LFMD) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 10 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for LFMD is $8.50, representing a +121.9% upside from the current price of $3.83. Price targets range from a low of $6.00 to a high of $10.00.
